100% Genuine Products, Guaranteed
Safe & Secure Payments, Always
Fast, Secure & Efficient Delivery
Proper Packaging
Show More
discontinued. Unless patients are monitored for potential increases in blood pressure, Zolivox should not be administered to patients with uncontrolled hypertension, pheochromocytoma, thyrotoxicosis and/or patients taking sympathomimetic agents, vasopressive agents and dopaminergic agents. Patients who develop recurrent nausea or vomiting, unexplained acidosis or low bicarbonate level while receiving Zolivox should receive immediate medical evaluation. If hypoglycemia occurs, a decrease in the dose of insulin or oral hypoglycemic agent or discontinuation of oral hypoglycemic agent, insulin or Zolivox may be required.
No cases of overdose have been reported. Symptomatic and supportive care is advised together with maintenance of glomerular filtration. Approximately 30% of a Zolivox dose is removed during 3 hours of haemodialysis. No data are available for the removal of Zolivox by peritoneal dialysis or haemoperfusion.
Macrolides
Reconstitution of Oral Suspension: Shake the bottle to loosen powder. Add 75 ml (with the help of given cup) of boiled and cooled water to the dry mixture in the bottle. For the ease of preparation, add water to the bottle in two portions. Shake well after each addition until all the powder is in suspension.
Note: Shake the suspension well before each use. Keep the bottle tightly closed. The reconstituted suspension should be stored in a cool and dry place. Use within 21 days after constitution.
Intravenous Administration: Zolivox IV Injection is supplied in single-use, ready-to-use infusion bottles. Zolivox IV Injection should be administered by intravenous infusion over a period of 30 to 120 minutes. The intravenous infusion bottles should not be used in series connections. Additives should not be introduced into this solution. The infusion bottles should be stored at room temperature and protected from freezing. Zolivox IV Injection may exhibit a yellow color that can intensify over time without adversely affecting potency.
Zolivox formulations should be stored at room temperature (15°C-30°C), away from light and moisture. All medicines should be kept away from children.
Disclaimer:
ePharma sole intention is to ensure that its consumers get proper
information as musch as possible. Although we do not guarantee the
accuracy and the completeness of the information that provided and
here information is for informational purposes only.
The information contained herein should NOT be used as a substitute
for the advice of a qualified physician. This may not cover
everything about particular health conditions,
lab tests, medicines, all possible side effects, drug interactions,
warnings, alerts, etc. Please consult your healthcare professional
and discuss all your queries related to any disease or medicine. We
intend to support, not replace, the doctor-patient relationship.